川鲁两省八家中成药企业知识产权现状与启示  

Present Situation and Enlightenment of Intellectual Property Rights of 8Proprietary Chinese Medicine Enterprises in Sichuan and Shandong Province

作　　者：王树华[1] 杨年富[2] 

机构地区：[1]潍坊医学院卫生管理学院 [2]成都中医药大学

出　　处：《医学与法学》2013年第6期50-52,共3页Medicine and Jurisprudence

基　　金：四川医事卫生法治研究中心立项资助项目"全球化背景下中药保护研究"(项目编号:YF09-Q11);教育部人文社会科学青年基金资助项目"全球化背景下中药传统文化保护研究"(项目编号:10YJC820135)的阶段性成果

摘　　要：中药为国民健康作出了贡献并已成为世界医学的重要内容,但中国中成药企业却没有因此而繁荣。文章通过分析对川鲁两省八家中成药企业的知识产权进行调研的数据,得出了与现有观点不同的结论,认为中成药企业重视运用专利、商标、新药和中药保护品种进行保护,但缺乏利用原产地域产品保护和原产地标记进行保护的意识,而且利用商业秘密和国家秘密进行保护的也较少。Traditional Chinese medicine （TCM） has made contribution to Chinese people＇s health and has become an important part of the world medicine, but it does not result in the prosperity of proprietary Chinese medicine enterprises in China. By analyzing intellectual property data from eight proprietary Chinese medicine enterprises in Sichuan and Shandong province, this paper comes to conclusions different from current views： pro- prietary Chinese medicine enterprises attach importance to patents, trademarks, new drugs and protection species of traditional Chinese medicine; meanwhile, they lack the consciousness of protection by geographical origin of products and marks of origin; and only a few of them protect by trade secrets and state secrets.

关 键 词：中成药 企业 知识产权 

分 类 号：D923.4[政治法律—民商法学] F426.72[政治法律—法学]